Health & Environmental Research Online (HERO)


Print Feedback Export to File
5101419 
Journal Article 
Analysis of glycerophospholipid metabolism after exposure to PCB153 in PC12 cells through targeted lipidomics by UHPLC-MS/MS 
Wang, X; Xu, Y; Song, X; Jia, Q; Zhang, X; Qian, Y; Qiu, J 
2019 
Yes 
Ecotoxicology and Environmental Safety
ISSN: 0147-6513
EISSN: 1090-2414 
169 
120-127 
English 
Polychlorinated biphenyls (PCBs) are persistent organic pollutants (POPs) that have neurotoxicity, reproductive toxicity, hepatotoxicity and immunotoxicity in both animals and humans. Few studies have focused on the changes to endogenous glycerophospholipid metabolism caused by PCB153. To evaluate the relationships between exposure to PCB153 and specific endogenous glycerophospholipid metabolism, an ultra-high-performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method was implemented in this study. Twenty-two endogenous glycerophospholipids in PC12 cells were analyzed after exposure to PCB153 at dosages of 0.05 μg mL-1, 0.5 μg mL-1 or 20 μg mL-1 for 120 h. PC(14:0/14:0), PE(16:0/18:1), PE(16:0/18:2), PS(18:0/18:1) and PI(16:0/18:1) were identified as potential biomarkers under the rules of t-test (P) value < 0.05 and variable importance at projection (VIP) value > 1. It was also found that the alterations at 0.05 μg mL-1 and 20 μg mL-1 PCB153 were similar at 120 h, while 0.5 μg mL-1 PCB153 presented an opposite trend. Additionally, significant upregulation of PC, PE and PS with the same fatty acid chains of 18:0/18:2 was found after exposure to 0.05 μg mL-1 and 20 μg mL-1 PCB153 at 120 h. This study revealed that PCB153 exposure modulated 22 endogenous glycerophospholipids in PC12 cells and provided the basis for the further study of PCB153 on the effects of glycerophospholipids on PC12 cells. 
IRIS
• Methylmercury
     Literature Search: Mar 2017 - May 2019
          Human Data
          WoS
• PCBs
     Not prioritized for screening
     Litsearches
          Litsearch: Aug 2018 - Aug 2019
               PubMed
               Not prioritized for screening